Clinical trial
Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic…
NCT00491374 · Schering-Plough, Industry · Terminated
Key facts
| NCT number | NCT00491374 |
|---|---|
| Title | Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED) |
| Official title | A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study Of Mometasone Furoate Nasal Spray (MFNS) In Subjects With Mild-Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Associated With Perennial Allergic Rhinitis (PAR) Using Polysomnographic Recordings of Sleep… |
| Lead sponsor | Schering-Plough, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Perennial Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Mometasone Furoate Nasal Spray, Placebo |
| Enrollment | 0 |
| Start date | Sep 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Jun 26, 2007 |
| Last update posted | Jan 6, 2009 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: